Sepideh Amin-Hanjani1, Xinjian Du2, Linda Rose-Finnell2, Dilip K Pandey2, DeJuran Richardson2, Keith R Thulborn2, Mitchell S V Elkind2, Gregory J Zipfel2, David S Liebeskind2, Frank L Silver2, Scott E Kasner2, Victor A Aletich2, Louis R Caplan2, Colin P Derdeyn2, Philip B Gorelick2, Fady T Charbel2. 1. From the Department of Neurosurgery (S.A.-H., X.D., L.R.-F., V.A.A., F.T.C.), Department of Neurology and Rehabilitation (D.K.P., D.R.), and Center for Magnetic Resonance Research (K.R.T.), University of Illinois at Chicago; Department of Mathematics and Computer Science, Lake Forest College, IL (D.R.); Departments of Neurology and Epidemiology, Columbia University, New York, NY (M.S.V.E.); Departments of Neurosurgery and Neurology, Washington University in St. Louis, MO (G.J.Z., C.P.D.); Department of Neurology, University of California at Los Angeles (D.S.L.); Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada (F.L.S.); Department of Neurology, University of Pennsylvania, Philadelphia (S.E.K.); Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (L.R.C.); Departments of Radiology, Neurology and Neurological Surgery, Mallinkrodt Institute of Radiology, Washington University in St. Louis, MO (C.P.D.); and Department of Translational Science and Molecular Medicine, Michigan State University College of Human Medicine, and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.). hanjani@uic.edu. 2. From the Department of Neurosurgery (S.A.-H., X.D., L.R.-F., V.A.A., F.T.C.), Department of Neurology and Rehabilitation (D.K.P., D.R.), and Center for Magnetic Resonance Research (K.R.T.), University of Illinois at Chicago; Department of Mathematics and Computer Science, Lake Forest College, IL (D.R.); Departments of Neurology and Epidemiology, Columbia University, New York, NY (M.S.V.E.); Departments of Neurosurgery and Neurology, Washington University in St. Louis, MO (G.J.Z., C.P.D.); Department of Neurology, University of California at Los Angeles (D.S.L.); Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada (F.L.S.); Department of Neurology, University of Pennsylvania, Philadelphia (S.E.K.); Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (L.R.C.); Departments of Radiology, Neurology and Neurological Surgery, Mallinkrodt Institute of Radiology, Washington University in St. Louis, MO (C.P.D.); and Department of Translational Science and Molecular Medicine, Michigan State University College of Human Medicine, and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.).
Abstract
BACKGROUND AND PURPOSE: Atherosclerotic vertebrobasilar disease is an important cause of posterior circulation stroke. To examine the role of hemodynamic compromise, a prospective multicenter study, Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS), was conducted. Here, we report clinical features and vessel flow measurements from the study cohort. METHODS: Patients with recent vertebrobasilar transient ischemic attack or stroke and ≥50% atherosclerotic stenosis or occlusion in vertebral or basilar arteries (BA) were enrolled. Large-vessel flow in the vertebrobasilar territory was assessed using quantitative MRA. RESULTS: The cohort (n=72; 44% women) had a mean age of 65.6 years; 72% presented with ischemic stroke. Hypertension (93%) and hyperlipidemia (81%) were the most prevalent vascular risk factors. BA flows correlated negatively with percentage stenosis in the affected vessel and positively to the minimal diameter at the stenosis site (P<0.01). A relative threshold effect was evident, with flows dropping most significantly with ≥80% stenosis/occlusion (P<0.05). Tandem disease involving the BA and either/both vertebral arteries had the greatest negative impact on immediate downstream flow in the BA (43 mL/min versus 71 mL/min; P=0.01). Distal flow status assessment, based on an algorithm incorporating collateral flow by examining distal vessels (BA and posterior cerebral arteries), correlated neither with multifocality of disease nor with severity of the maximal stenosis. CONCLUSIONS: Flow in stenotic posterior circulation vessels correlates with residual diameter and drops significantly with tandem disease. However, distal flow status, incorporating collateral capacity, is not well predicted by the severity or location of the disease.
BACKGROUND AND PURPOSE:Atherosclerotic vertebrobasilar disease is an important cause of posterior circulation stroke. To examine the role of hemodynamic compromise, a prospective multicenter study, Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS), was conducted. Here, we report clinical features and vessel flow measurements from the study cohort. METHODS:Patients with recent vertebrobasilar transient ischemic attack or stroke and ≥50% atherosclerotic stenosis or occlusion in vertebral or basilar arteries (BA) were enrolled. Large-vessel flow in the vertebrobasilar territory was assessed using quantitative MRA. RESULTS: The cohort (n=72; 44% women) had a mean age of 65.6 years; 72% presented with ischemic stroke. Hypertension (93%) and hyperlipidemia (81%) were the most prevalent vascular risk factors. BA flows correlated negatively with percentage stenosis in the affected vessel and positively to the minimal diameter at the stenosis site (P<0.01). A relative threshold effect was evident, with flows dropping most significantly with ≥80% stenosis/occlusion (P<0.05). Tandem disease involving the BA and either/both vertebral arteries had the greatest negative impact on immediate downstream flow in the BA (43 mL/min versus 71 mL/min; P=0.01). Distal flow status assessment, based on an algorithm incorporating collateral flow by examining distal vessels (BA and posterior cerebral arteries), correlated neither with multifocality of disease nor with severity of the maximal stenosis. CONCLUSIONS: Flow in stenotic posterior circulation vessels correlates with residual diameter and drops significantly with tandem disease. However, distal flow status, incorporating collateral capacity, is not well predicted by the severity or location of the disease.
Authors: Sepideh Amin-Hanjani; Xinjian Du; Dilip K Pandey; Keith R Thulborn; Fady T Charbel Journal: J Cereb Blood Flow Metab Date: 2014-11-12 Impact factor: 6.200
Authors: Sepideh Amin-Hanjani; Linda Rose-Finnell; DeJuran Richardson; Sean Ruland; Dilip Pandey; Keith R Thulborn; David S Liebeskind; Gregory J Zipfel; Mitchell S V Elkind; Jeffrey Kramer; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel Journal: Int J Stroke Date: 2010-12 Impact factor: 5.266
Authors: Ahmad R Abuzinadah; Mohammed H Alanazy; Mohammed A Almekhlafi; Yanjune Duan; Haifeng Zhu; Mikael Mazighi; Helmi L Lutsep; Tyrone Donnon; Michael D Hill Journal: J Neurointerv Surg Date: 2014-12-11 Impact factor: 5.836
Authors: Louis R Caplan; Robert J Wityk; Thomas A Glass; Jorge Tapia; Ladislav Pazdera; Hui-Meng Chang; Phillip Teal; John F Dashe; Claudia J Chaves; Joan C Breen; Kostas Vemmos; Pierre Amarenco; Barbara Tettenborn; Megan Leary; Conrad Estol; L Dana Dewitt; Michael S Pessin Journal: Ann Neurol Date: 2004-09 Impact factor: 10.422
Authors: R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers Journal: JAMA Date: 1998 Sep 23-30 Impact factor: 56.272
Authors: Sepideh Amin-Hanjani; Christopher J Stapleton; Xinjian Du; Linda Rose-Finnell; Dilip K Pandey; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel Journal: Stroke Date: 2019-02 Impact factor: 7.914
Authors: Sepideh Amin-Hanjani; Dilip K Pandey; Linda Rose-Finnell; Xinjian Du; DeJuran Richardson; Keith R Thulborn; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Victor A Aletich; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel Journal: JAMA Neurol Date: 2016-02 Impact factor: 18.302
Authors: Sepideh Amin-Hanjani; Alfred P See; Xinjian Du; Linda Rose-Finnell; Dilip K Pandey; Yi-Fan Chen; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Philip B Gorelick; Fady T Charbel; Colin P Derdeyn Journal: Stroke Date: 2020-10-09 Impact factor: 7.914
Authors: Christopher J Stapleton; Yi-Fan Chen; Hussain Shallwani; Kunal Vakharia; Tanya N Turan; Henry H Woo; Colin P Derdeyn; Fady T Charbel; Adnan H Siddiqui; Sepideh Amin-Hanjani Journal: Neurosurgery Date: 2020-06-01 Impact factor: 4.654
Authors: Sepideh Amin-Hanjani; Tanya N Turan; Xinjian Du; Dilip K Pandey; Linda Rose-Finnell; DeJuran Richardson; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Philip B Gorelick; Fady T Charbel; Colin P Derdeyn Journal: J Stroke Cerebrovasc Dis Date: 2016-10-28 Impact factor: 2.136
Authors: Shadi Yaghi; George Cotsonis; Adam de Havenon; Shyam Prahbakaran; Jose G Romano; Ronald M Lazar; Randolph S Marshall; Edward Feldmann; David S Liebeskind Journal: J Stroke Cerebrovasc Dis Date: 2020-02-07 Impact factor: 2.136